Zentalis Pharmaceuticals (ZNTL) Goodwill & Intangibles (2019 - 2024)

Zentalis Pharmaceuticals has reported Goodwill & Intangibles for 6 years, with the latest figure at $3.7 million in Q3 2024.

• For the quarter ending Q3 2024, Goodwill & Intangibles changed 0.0% year-over-year to $3.7 million; the trailing twelve-month figure through Sep 2024 stood at $3.7 million (changed 0.0% YoY), and the FY2023 full-year result was $3.7 million, changed 0.0% from the prior year.
• Goodwill & Intangibles for Q3 2024 stood at $3.7 million, roughly flat from $3.7 million in the prior quarter.
• The five-year high for Goodwill & Intangibles was $12.5 million in Q1 2020, with the low at $3.7 million in Q3 2021.
• Average Goodwill & Intangibles over 5 years is $6.5 million, with a median of $3.7 million recorded in 2021.
• Year-over-year, Goodwill & Intangibles changed 0.0% in 2020 and sank 70.2% in 2021.
• Tracing ZNTL's Goodwill & Intangibles over 5 years: stood at $12.5 million in 2020, then slumped by 70.2% to $3.7 million in 2021, then changed by 0.0% to $3.7 million in 2022, then changed by 0.0% to $3.7 million in 2023, then changed by 0.0% to $3.7 million in 2024.
• The last three Goodwill & Intangibles figures came in at $3.7 million (Q3 2024), $3.7 million (Q2 2024), and $3.7 million (Q1 2024), per Business Quant data.

Peer Comparison